Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of -21.41% is 53% above its 5-year average of -45.48%, near the high end of its 5-year range (-347.86%–4.74%).
As of the fiscal period ended Tuesday, June 30, 2026. 161.29% below its 12-month average of -8.19%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q1 FY2027 (2026-06-30): -21.41%.
RETURN ON EQUITY (ROE)
-21.41%
RETURN ON EQUITY (ROE) AVG TTM
-8.19%
RETURN ON EQUITY (ROE) AVG 3Y
-12.96%
RETURN ON EQUITY (ROE) AVG 5Y
-45.48%
RETURN ON EQUITY (ROE) AVG 10Y
-36.06%
RETURN ON EQUITY (ROE) AVG 15Y
-24.78%
RETURN ON EQUITY (ROE) AVG 20Y
N/A
CURRENT VS TTM AVG
-161.29%
CURRENT VS 3Y AVG
-65.19%
CURRENT VS 5Y AVG
+52.93%
CURRENT VS 10Y AVG
+40.63%
CURRENT VS 15Y AVG
+13.61%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-39.44%
median of 550 covered companies
CURRENT VS SECTOR MEDIAN
+45.71%
vs the sector median at left
Aurora Cannabis Inc.
Market Cap
$276.57M
Return on Equity (ROE)
-21.41%
TTM Avg
-8.19%
3Y Avg
-12.96%
5Y Avg
-45.48%
Market Cap
$274.50M
Return on Equity (ROE)
-82.12%
TTM Avg
-62.12%
3Y Avg
-56.53%
5Y Avg
-50.41%
Market Cap
$272.91M
Return on Equity (ROE)
-135.62%
TTM Avg
-521.17%
3Y Avg
-307.05%
5Y Avg
43.03%
Market Cap
$282.07M
Return on Equity (ROE)
-27.36%
TTM Avg
-12.73%
3Y Avg
-30.52%
5Y Avg
-39.12%
Market Cap
$284.12M
Return on Equity (ROE)
-49.11%
TTM Avg
-50.02%
3Y Avg
-153.47%
5Y Avg
-149.41%
Market Cap
$266.10M
Return on Equity (ROE)
-15.46%
TTM Avg
-12.46%
3Y Avg
-4.29%
5Y Avg
-4.49%
Market Cap
$289.31M
Return on Equity (ROE)
-135.50%
TTM Avg
-129.54%
3Y Avg
-84.04%
5Y Avg
-77.00%
Market Cap
$263.68M
Return on Equity (ROE)
-184.27%
TTM Avg
-57.34%
3Y Avg
-61.84%
5Y Avg
-87.31%
Market Cap
$262.58M
Return on Equity (ROE)
-124.67%
TTM Avg
-101.06%
3Y Avg
-69.44%
5Y Avg
-56.33%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Aurora Cannabis Inc. (ACB) | $276.57M | -21.41% | -8.19% | -12.96% | -45.48% |
| Fate Therapeutics, Inc. (FATE)vs › | $274.50M | -82.12% | -62.12% | -56.53% | -50.41% |
| Indaptus Therapeutics, Inc. (INDP)vs › | $272.91M | -135.62% | -521.17% | -307.05% | 43.03% |
| Fulcrum Therapeutics, Inc. (FULC)vs › | $282.07M | -27.36% | -12.73% | -30.52% | -39.12% |
| Abeona Therapeutics Inc. (ABEO)vs › | $284.12M | -49.11% | -50.02% | -153.47% | -149.41% |
| OraSure Technologies, Inc. (OSUR)vs › | $266.10M | -15.46% | -12.46% | -4.29% | -4.49% |
| Larimar Therapeutics, Inc. (LRMR)vs › | $289.31M | -135.50% | -129.54% | -84.04% | -77.00% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $263.68M | -184.27% | -57.34% | -61.84% | -87.31% |
| AC Immune S.A. (ACIU)vs › | $262.58M | -124.67% | -101.06% | -69.44% | -56.33% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $262.48M | -38.33% | -61.68% | -393.03% | -278.88% |
ROE
-21.4%
ROA
-18.2%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | -21.41% |
| 2026-03-31 | -14.47% |
| 2025-12-31 | -7.54% |
| 2025-09-30 | -2.29% |
| 2025-06-30 | 4.74% |
| 2025-03-31 | 0.21% |
| 2024-12-31 | 1.26% |
| 2024-09-30 | -7.45% |
| 2024-06-30 | -5.20% |
| 2024-03-31 | -11.19% |
| 2023-12-31 | -24.01% |
| 2023-09-30 | -34.89% |
| 2023-06-30 | -46.24% |
| 2023-03-31 | -172.48% |
| 2022-12-31 | -336.42% |
| 2022-09-30 | -347.86% |
| 2022-06-30 | -264.24% |
| 2022-03-31 | -258.09% |
| 2021-12-31 | -77.96% |
| 2021-09-30 | -108.64% |
| 2021-06-30 | -32.98% |
| 2021-03-31 | -104.88% |
| 2020-12-31 | -103.48% |
| 2020-09-30 | -158.30% |
| 2020-06-30 | -156.53% |
| 2020-03-31 | -39.28% |
| 2019-12-31 | -36.40% |
| 2019-09-30 | -8.46% |
| 2019-06-30 | -6.27% |
| 2019-03-31 | -4.55% |
| 2018-12-31 | -1.47% |
| 2018-09-30 | 3.90% |
| 2018-06-30 | 4.59% |
| 2018-03-31 | -0.90% |
| 2017-12-31 | 1.22% |
| 2017-09-30 | -1.46% |
| 2017-06-30 | -5.83% |
| 2017-03-31 | -10.06% |
| 2016-12-31 | -19.07% |
| 2016-09-30 | -26.65% |
| 2016-06-30 | -99.85% |
| 2016-03-31 | 15.31% |
| 2015-12-31 | 19.46% |
| 2015-09-30 | 30.70% |
| 2015-06-30 | 55.47% |
| 2015-03-31 | -151.62% |
| 2014-12-31 | -63.74% |
| 2014-09-30 | -19.25% |
| 2014-06-30 | -29.40% |
| 2014-03-31 | -48.07% |
| 2013-12-31 | -40.46% |
| 2013-09-30 | -44.02% |
| 2013-06-30 | -59.36% |
| 2013-03-31 | -61.89% |
| 2012-12-31 | -51.90% |
| 2012-09-30 | -44.30% |
| 2012-06-30 | -29.31% |
| 2012-03-31 | -13.51% |
| 2011-12-31 | -27.94% |
| 2011-09-30 | -28.81% |
| 2011-06-30 | -25.40% |
| 2011-03-31 | -23.93% |
| 2010-12-31 | -9.03% |
| 2010-09-30 | -6.99% |
| 2010-06-30 | -6.05% |
| 2010-03-31 | -4.14% |
| 2009-12-31 | -3.91% |
| 2009-09-30 | -4.92% |
| 2009-06-30 | -9.23% |
| 2009-03-31 | -10.44% |
| 2008-12-31 | -8.58% |
| 2008-09-30 | -15.72% |
| 2008-06-30 | -10.71% |
